Abstract
Blood biomarkers are still largely missing in hereditary spastic paraplegias (HSPs). We here explored Neurofilament light chain (NfL) as a biomarker in HSP. Serum NfL was assessed in 96 HSP (63 genetically confirmed), 96 healthy control, and 33 ALS subjects by single molecule array (Simoa). Compared to controls, NfL was increased in HSP (P < 0.001), correlating with cross-sectional disease progression (ρ = 0.28). Levels were lower than in ALS (P < 0.001), allowing to differentiate HSP from ALS (AUC = 0.91). Serum NfL might serve as a biomarker in HSP indicating neuronal damage and, if confirmed longitudinally, disease progression. It might also support differentiating HSP from ALS.
References
May 21, 1983·Lancet·A E Harding
Aug 9, 2006·Neurology·R SchüleL Schöls
Oct 24, 2014·Neurology·Tobias SkillbäckHenrik Zetterberg
May 3, 2015·Neurology·Ching-Hua LuAndrea Malaspina
Aug 15, 2015·Annals of Clinical and Translational Neurology·Ricarda A L MenkeMartin R Turner
Nov 4, 2015·Annals of Neurology·Patrick WeydtMarkus Otto
Feb 10, 2016·Annals of Neurology·Rebecca SchüleLudger Schöls
Apr 14, 2016·Clinical Chemistry and Laboratory Medicine : CCLM·Jens KuhleHenrik Zetterberg
May 18, 2016·Journal of Neurology, Neurosurgery, and Psychiatry·Carlo WilkeMatthis Synofzik
May 28, 2016·Scientific Reports·Gautam WaliAlan Mackay-Sim
Jun 14, 2016·Neuron·Mehtap BaciogluMathias Jucker
Jul 9, 2016·Neuron·Henrik Zetterberg
Sep 2, 2016·Neurology·Jonathan D RohrerHenrik Zetterberg
Feb 10, 2017·Neurology·Oskar HanssonUNKNOWN Swedish BioFINDER study
Mar 7, 2017·JAMA Neurology·Alessandra GaianiGianni Sorarù
May 18, 2017·Annals of Neurology·Giulio DisantoUNKNOWN Swiss Multiple Sclerosis Cohort Study Group
Oct 20, 2017·Neurology·Thomas GattringerMichael Khalil
Nov 11, 2017·Brain : a Journal of Neurology·Ludger SchölsRebecca Schüle
Dec 8, 2017·Neurology·Emily FenebergMarkus Otto
Dec 12, 2017·Brain : a Journal of Neurology·Cecilia MarelliFanny Mochel
Jan 13, 2018·Neurology·Åsa SandeliusAlexander M Rossor
Citations
Jan 8, 2020·Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring·Lauren M ForgraveMari L DeMarco
Feb 27, 2020·Journal of Neurology·Samir Abu-RumeilehUNKNOWN BoReALS
Feb 1, 2020·Journal of Neurology·Stefanie Nicole HayerUNKNOWN EFACTS study group
Oct 14, 2020·Annals of Clinical and Translational Neurology·Wouter J C van BallegoijMarc Engelen
Dec 20, 2020·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·Elina MillereViktorija Kenina
Jan 12, 2021·Frontiers in Neurology·Kazuo SugimotoYing Gao
Feb 27, 2021·Neurobiology of Disease·Giulia CoarelliAlexandra Durr
Apr 1, 2021·Scientific Reports·Tim W RattayDirk Wildgruber
Apr 6, 2021·Annals of Clinical and Translational Neurology·Christoph KesslerRebecca Schüle
Jun 3, 2021·Brain Sciences·Timothy Fullam, Jeffrey Statland
Aug 18, 2021·Current Opinion in Neurobiology·Frédéric DariosAlexandra Durr
Oct 17, 2020·Molecular Neurodegeneration·Elisabetta ZucchiJessica Mandrioli
Nov 15, 2018·Neuro-degenerative Diseases·Elisabetta ZucchiJessica Mandrioli
Nov 8, 2021·Annals of Neurology·Carlo WilkeMatthis Synofzik
Dec 8, 2021·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·Giacomo SferruzzaNilo Riva